Cargando…

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection

Vaccination with J8-DT, a leading GAS vaccine candidate, results in protective immunity in mice. Analysis of immunologic correlates of protection indicated a role of J8-specific antibodies that were induced post-immunization. In the present study, several independent experimental approaches were emp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Manisha, Batzloff, Michael R., Good, Michael F.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660439/ https://www.ncbi.nlm.nih.gov/pubmed/19340309 http://dx.doi.org/10.1371/journal.pone.0005147

Ejemplares similares

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial
por: Sekuloski, Silvana, et al.
Publicado: (2018)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy
por: Pandey, Manisha, et al.
Publicado: (2018)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
por: Reynolds, Simone, et al.
Publicado: (2023)

Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
por: Rivera-Hernandez, Tania, et al.
Publicado: (2016)

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023)

Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus
por: Henningham, Anna, et al.
Publicado: (2013)

M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus
por: Tsoi, Shu Ki, et al.
Publicado: (2015)

The quest for GAS vaccine
por: Pandey, Manisha, et al.
Publicado: (2015)

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
por: Ozberk, Victoria, et al.
Publicado: (2021)

Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
por: Plumb, J. A., et al.
Publicado: (1994)

An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
por: Rivera-Hernandez, Tania, et al.
Publicado: (2019)

Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation
por: Cohen, Jonathan M., et al.
Publicado: (2012)

Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
por: Campisi, Edmondo, et al.
Publicado: (2021)

CERN. EP Department. DT Group: Annual report
Publicado: (2016)

Identification and characterization of protective CD8(+) T‐epitopes in a malaria vaccine candidate SLTRiP
por: Quadiri, Afshana, et al.
Publicado: (2020)

DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough
por: Pelleg, Amir, et al.
Publicado: (2019)

Toward the development of a protein-based group B Streptococcus vaccine
por: Dominguez, Kristen, et al.
Publicado: (2022)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
por: Loh, Jacelyn M. S., et al.
Publicado: (2017)

Novel approaches to identify protective malaria vaccine candidates
por: Chia, Wan Ni, et al.
Publicado: (2014)

Structures of (5′S)-8,5′-Cyclo-2′-deoxyguanosine Mismatched with dA or dT
por: Huang, Hai, et al.
Publicado: (2012)

Erratum for Rivera-Hernandez et al., “An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model”
por: Rivera-Hernandez, Tania, et al.
Publicado: (2020)

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma
por: Pandey, Manisha, et al.
Publicado: (2016)

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007
por: Steer, Andrew C., et al.
Publicado: (2009)

Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection
por: Masomian, Malihe, et al.
Publicado: (2020)

Muon DT Upgrade
por: Fernandez Bedoya, Cristina
Publicado: (2011)

MUON DETECTORS: DT
por: A. Benvenuti, et al.
Publicado: (2009)

MUON DETECTORS: DT
por: Marco Dallavalle
Publicado: (2009)

DT Mental health
Publicado: (2022)

Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection
por: Chiarot, Emiliano, et al.
Publicado: (2021)

Multiply Resistant (MR) Salmonella enterica Serotype Typhimurium DT 12 and DT 120: A Case of MR DT 104 in Disguise?
por: Lawson, Andrew J., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_msa6jqijf6o57hqiiom4jgtcar